tiprankstipranks
Trending News
More News >
AEON Biopharma (AEON)
:AEON
US Market
Advertisement

AEON Biopharma (AEON) Price & Analysis

Compare
209 Followers

AEON Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Cost ManagementR&D expenses declined 50.8% YoY to $4.4M, which were below the estimate, indicating effective cost management.
Regulatory ApprovalAeon finds alignment with the FDA on key biosimilar pathway requirements, boosting confidence in potential regulatory approval.
Bears Say
Funding UncertaintyGiven the uncertainty in funding, the price target is adjusted to $5 from $6, reflecting potential financial challenges.
Production DependencyAeon relies on Daewoong to manufacture ABP-450, and any production issues with Daewoong could adversely impact Aeon.

Financials

Options Prices

Currently, No data available
---

Ownership Overview

16.05%0.07%<0.01%83.84%
16.05% Insiders
<0.01% Other Institutional Investors
83.84% Public Companies and
Individual Investors

AEON FAQ

What was AEON Biopharma’s price range in the past 12 months?
AEON Biopharma lowest stock price was $0.38 and its highest was $215.28 in the past 12 months.
    What is AEON Biopharma’s market cap?
    AEON Biopharma’s market cap is $8.84M.
      When is AEON Biopharma’s upcoming earnings report date?
      AEON Biopharma’s upcoming earnings report date is Aug 18, 2025 which is in 27 days.
        How were AEON Biopharma’s earnings last quarter?
        Currently, no data Available
        Is AEON Biopharma overvalued?
        According to Wall Street analysts AEON Biopharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does AEON Biopharma pay dividends?
          AEON Biopharma does not currently pay dividends.
          What is AEON Biopharma’s EPS estimate?
          AEON Biopharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does AEON Biopharma have?
          AEON Biopharma has 11,305,367 shares outstanding.
            What happened to AEON Biopharma’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of AEON Biopharma?
            Among the largest hedge funds holding AEON Biopharma’s share is Saba Capital Management. It holds AEON Biopharma’s shares valued at 0.

              Company Description

              AEON Biopharma

              AEON Biopharma (AEON) is a clinical-stage biopharmaceutical company that focuses on developing and commercializing therapeutic treatments targeting neurological and gastroenterological disorders. The company is engaged in the research and development of therapeutic applications for botulinum toxin complex, aiming to address unmet medical needs in various indications such as chronic migraine, cervical dystonia, and other related conditions.
              Similar Stocks
              Company
              Price & Change
              Follow
              Oruka Therapeutics
              Cytokinetics
              Rigel
              Fate Therapeutics
              Karyopharm Therapeutics
              Atara Biotherapeutics
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis